Pure Labs
Tampa, FLA, March 16, 2021 (GLOBE NEWSWIRE) -- Nicopure Labs announces that the Food and Drug Association (FDA) has Accepted all Halo Products Pre-Market Tobacco Applications for the Substantive Scientific Review phase.
Just over 6 months after submission, Nicopure Labs’ Pre-Market Tobacco Applications for Halo Turkish Tobacco E-liquid, Halo Triton II Starter Kit, Halo ZERO Starter Kit, and all supporting consumable components, have been Accepted and advanced to the final phase, Substantive Scientific Review by the FDA. This after Halo’s first round of products was rapidly Accepted and advanced, three days after submission.
"Halo’s more than 12 years’ of commitment to producing the highest quality vaping products available for adult consumers has been our organization's mission for more than a decade.", said Jeffrey Stamler, Co-Founder Nicopure Labs. "We believe in science and we believe in transparency, we are honored to continue to work with the FDA, and as always, in the best interest of the industry and the most important thing of them all, our loyal customers", said Stamler.
Halo FDA Accepted Premarket Tobacco Applications Include:
- Halo Tribeca Tobacco E-liquid
- Halo SubZero Menthol E-liquid
- Halo Turkish Tobacco E-liquid
- Halo Fusion Unflavored Tobacco E-liquid
- Halo Triton II Starter Kit (and supporting consumable components)
- Halo ZERO Starter Kit (and supporting consumable components)
About Pure Laboratories
Operating since 2009, Gainesville-based Pure Laboratories LLC, also known as Pure Labs and subsidiary’s, including Nicopure Labs is the industry leading tobacco and menthol e-liquid manufacturer that produces award-winning products in the USA, sold in over 100 countries. Pure Labs has a state-of-the-art 110,000-sq. ft. manufacturing and distribution facility in Gainesville, Florida with a 10,000-sq. ft. ISO 7 cleanroom, Headquarters based in Tampa, Florida, as well as European Operations.
For additional information about carrying Halo’s premium American-made e-liquids and innovative line of vaporizer devices, please visit www.halowholesaledirect.com.
For additional information on Pure Laboratories full capabilities visit www.PureLabs.com.
For media inquiries, please email press@purelabs.com.
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Solvay S.A.14.7.2025 19:18:08 CEST | Press release
Solvay revises its 2025 underlying EBITDA outlook and confirms its Free cash flow guidance
Strategic Partners A/S14.7.2025 19:13:26 CEST | Pressemeddelelse
Storaktionærmeddelelse
Strategic Partners A/S14.7.2025 19:09:25 CEST | Pressemeddelelse
Ledende medarbejders transaktioner
Zoom Communications, Inc.14.7.2025 17:40:44 CEST | Press release
Zoom recognized as a leader in Unified-Communications-As-A-Service platforms by leading global research firm
Siili Solutions Oyj14.7.2025 17:30:00 CEST | Press release
Siili Solutions Plc: Share Repurchase 14.7.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom